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Abstract
Purpose: The coronavirus disease 2019 (COVID-19) pandem-
ic has put a substantial burden on the Italian healthcare sys-
tem, resulting in the restructuring of hospitals to care for CO-
VID-19 patients. However, this has likely impacted access to 
care for patients experiencing other conditions. We aimed to 
quantify the impact of COVID-19 on access to care for pa-
tients with urgent/emergent urological conditions through-
out Italy. Materials and Methods: A questionnaire was sent 
to 33 urological units in the AGILE consortium, asking clini-
cians to report on the number of urgent/emergent urologi-
cal patients seen and/or undergoing surgery over a 3-week 
period during the peak of the COVID-19 outbreak and a ref-
erence week prior to the outbreak. ANOVA and linear regres-
sion models were used to quantify these changes. Results: 
Data from 27 urological centres in Italy showed a decrease 
from 956 patients/week seen just prior to the outbreak to 
291 patients/week seen by the end of the study period. 
There was a difference in the number of patients with ur-
gent/emergent urological disease seen within/during the 
different weeks (all p values < 0.05). A significant decrease in 
the number of patients presenting with haematuria, urinary 
retention, urinary tract infection, scrotal pain, renal colic, or 
trauma and urgent/emergent cases that required surgery 
was reported (all p values < 0.05). Conclusion: In Italy, during 
the COVID-19 outbreak there has been a decrease in patients 
seeking help for urgent/emergent urological conditions. Re-
structuring of hospitals and clinics is mandatory to cope with 
the COVID-19 pandemic; however, the healthcare system 
should continue to provide adequate levels of care also to 
patients with other conditions. © 2020 S. Karger AG, Basel
Introduction
At the end of December 2019, the World Health Orga-
nization reported on an outbreak of cases of pneumonia 
of an unknown aetiology in Wuhan City, Hubei Province, 
China. By January 7, 2020 the number of cases had grown 
rapidly, and the virus had been isolated and named SARS-
CoV-2 – colloquially known as the coronavirus – and the 
resulting disease was named coronavirus disease 2019 
(COVID-19) [1]. By the end of January 2020, the virus 
had spread beyond China, to 19 other countries. As of 
January 31, 2020, there were two confirmed cases in Italy 
[2]. The outbreak in Italy started in the Lombardy region, 
but quickly spread to the whole country. By March 30, 
2020, 97,689 confirmed cases and 10,779 deaths from the 
disease were reported in Italy [3].
In Italy, the exponential increase of cases led to an 
overtaxed health system, with a shortage of intensive care 
unit (ICU) beds and respiratory disease-related equip-
ment. In response, hospitals and clinics were reorganized 
to respond to the growing outbreak. Internal medicine 
departments and ICUs shifted to focus on critically ill pa-
tients with COVID-19 [4]. This led to a disruption in care 
of patients presenting with other symptoms or emergent 
conditions, including urgent and emergent urological 
conditions.
Urological emergencies, including lower and upper 
urinary tract obstruction, obstructive pyelonephritis, 
gross haematuria with clot retention, and trauma, are not 
uncommon disorders. A delay to promptly recognize 
these emergencies may potentially lead to serious impair-
ment such as renal failure, organ damage, or loss of sex-
ual function [5–7].
According to World Bank Staff estimates, Italy has the 
second largest proportion of older adults in the world [8]. 
Older adults are more susceptible and more strongly af-
fected by COVID-19, and they are also at greater risk of 
developing emergent urological conditions and relative 
complications.
The current multicentre study aimed to quantify 
changes in urgent and emergent urological care in Italy in 
the midst of the COVID-19 pandemic.
Materials and Methods
The AGILE group (Italian Group for Advanced Laparoscopic 
and Robotic Urologic Surgery) is a multicentre consortium con-
sisting of 33 private and public urological departments and clinics 
across Italy. Data from 27 of these centres were included in this 
study. As of March 29, 2020 a standardized questionnaire (Fig. 1) 
was e-mailed to each of the departments and a quick response was 
requested. The questionnaire asked urologists to record and sub-
mit data with regard to patients presenting with urgent and emer-
gent urological conditions (e.g., haematuria, urinary retention, 
urinary tract infection, scrotal pain, renal colic, and trauma) pre-
senting at their respective institutions, including the number of 
emergent/urgent urological cases and the number of urgent/emer-
gent cases that required surgery (e.g., endourological procedure, 
transurethral resection of bladder tumour, urethrotomy, and tes-
ticular detorsion). The included conditions and surgical proce-
dures were considered representative markers to evaluate the usu-
al urgent/emergent urological access. Accessibility to the emer-
gency department operating facilities were reported for the weeks 
of February 24, 2020, March 2, 2020, March 9, 2020, and – as a 




reference – a standard week (e.g., a week without holidays, confer-
ence, or other impending duties for the medical staff) before Feb-
ruary 22, 2020. Day clinicians reported data in real time, based on 
the scheduling in their hospital and in accordance with their re-
spective ethics committees. Additionally, we coded the 27 centres 
by geographic area as (1) Lombardy – the epicentre of the outbreak 
(5 centres), (2) neighbouring regions of Lombardy (11 centres), 
and (3) other Italian regions (11 centres).
In the analyses, we summarized urgent/emergent urological 
cases and stratified these data by type of case that presented. We 
used ANOVA to examine the change in the number of cases pre-
senting across the 4-week period. We additionally examined the 
linear trajectory of the number of urgent/emergent urological cas-
es seen across Italy during this period. All statistical analyses were 
performed with Stata version 15 (StataCorp LLC, College Station, 
TX, USA).
Please report the overall number of emergent/urgent urological cases that
presented at your institution in the given week
Please report the number of these cases that underwent surgery








Please report on the accessibility to emergency operating facilities:
• How many urgent/emergent interventions do you usually perform in a full week?
• Endourology (URS, ureteral stenting)
• Transurethral resection of bladder tumour
• Urethrotomy
• Testicular detorsion
The reference week could be of the clinicians’ choosing, but it had to be prior to the outbreak (prior to 2/22) and be a regular, full










Fig. 1. E-mail questionnaire sent to the participating urological departments and centers. URS, ureteroscopy.










Emergent/urgent cases, total 35.4 (24.3) 20.3 (15.3) 17.8 (14.2) 10.8 (11.8) <0.001
Emergent/urgent cases in surgery, total 8.7 (7.4) 4.4 (4.1) 3.6 (3.3) 3.4 (3.8) <0.001
Cases by type
Haematuria 7.1 (5.7) 4.3 (3.5) 3.4 (2.8) 2.2 (2.3) <0.001
Urinary retention 6.3 (5.7) 3.8 (3.6) 3.3 (3.2) 1.9 (2.4) <0.001
Urinary tract infection 4.4 (3.5) 2.2 (2.3) 2.2 (2.4) 1.1 (1.7) <0.001
Scrotal pain 3.7 (4.0) 2.1 (2.3) 1.6 (1.8) 0.9 (1.2) <0.001
Renal colic 10.9 (6.9) 7.1 (6.2) 6.3 (5.4) 3.9 (4.8) <0.001
Trauma 0.7 (0.8) 0.4 (0.8) 0.4 (0.6) 0.2 (0.6) 0.158
Emergency operating facilities
Endourology (URS, ureteral stenting) 5.0 (4.2) 2.9 (2.4) 2.2 (1.9) 2.2 (2.4) 0.002
Transurethral resection of bladder tumour 2.3 (3.0) 0.9 (1.9) 0.9 (1.6) 0.8 (1.3) 0.023
Urethrotomy 0.5 (0.8) 0.3 (0.6) 0.1 (0.5) 0.1 (0.4) 0.081
Testicular detorsion 0.8 (0.8) 0.4 (0.8) 0.2 (0.5) 0.2 (0.4) 0.006
Bold indicates statistical significance (p < 0.05). COVID-19, coronavirus disease 2019; URS, ureteroscopy.
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Results
Across 27 urological centres located throughout Italy, 
956 patients with urgent/emergent condition were seen 
in the reference week (prior to the COVID-19 outbreak), 
and this number decreased to 291 by the week of March 
9, 2020.
Using ANOVA models, we observed a statistically 
significant difference between weeks in number of 
overall (p < 0.001) and surgical (p < 0.001) urgent and 
emergent urological patients seen (Table 1). There were 
significant decreases in patients presenting with hae-
maturia (p < 0.001), urinary retention (p < 0.001), uri-
nary tract infection (p < 0.001), scrotal pain (p < 0.001), 
and renal colic (p < 0.001). Additionally, there were de-
creases in patients who underwent endourological pro-
cedures (p = 0.002), transurethral resection of bladder 
tumour (p = 0.023), and testicular detorsion (p = 0.006). 
The decrease was not significant for the number of trau-
ma or urethrotomy patients. Examining trends across 
the study period, we observed a significant linear de-
crease in both overall (B = –7.64, 95% CI –10.56 to 
–4.72, p < 0.001) and surgical (B = –1.66, 95% CI –2.51 
to –0.81, p < 0.001) patients (Fig.  2, 3). In sensitivity 
analyses, we investigated whether the area of Italy im-
pacted the observed trends in decreases in patients seen, 
but found no evidence of interaction by geographic 
area. Finally, we additionally investigated whether there 
were any differences between private and public or aca-
demic and non-academic institutions, but found no dif-
ferences.
Discussion
This multicentre study summarizes the change in ac-
cess to urgent urological care in Italy during the CO-
VID-19 pandemic. We found, across a 4-week period in-
cluding one reference week and 3 weeks during the peak 
of the COVID-19 pandemic, a progressive and significant 
decline of the overall accesses of urgent urological cases 
and of cases requiring urgent surgical management. We 
observed a significant decrease in nearly all types of cases, 
including haematuria, urinary retention, urinary tract in-
fection, scrotal pain, renal colic, endourological proce-
dure, transurethral resection of bladder tumour, and tes-
ticular detorsion. Moreover, in linear regression models, 
there was a significant, linear decrease in both number of 
surgical cases and overall cases. Interestingly, there was 
no difference in the number of cases seen across the 
4-week period based on proximity to Lombardy, the epi-
centre of the outbreak.
This decreased number of accesses might be justified 
by the restrictions applied in Italy. The restriction in 
movements of the population except for necessity, work, 
and health circumstances (the so-called lockdown) in re-
sponse to the growing pandemic might explain the reduc-
tion of patients who have hospital access for “not-essen-
tial” urgent urological consults. Also, staying home, rest-
ing, and avoiding exercise/outdoor activity may be a 
potential explanation for a decreased risk of certain con-
ditions (e.g., urological trauma or testicular torsion) [9].
Overall, the COVID-19 pandemic has a significant 



































B = –7.64, 95% CI –10.56, –4.72, p < 0.001
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B = –1.66, 95% CI –2.51, –0.81, p < 0.001
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Fig. 3. Trend with fit line of urgent and emergent surgical urolog-
ical cases.




logical diseases; the normal urological activity has been 
significantly reduced. For example, all this has led to 
relevant consequences on the execution of diagnostic 
tests even for the most frequent urological neoplasm 
including radiological examination [10]; consequently, 
access to even non-invasive treatments [11] and the 
consequent quality of life of this type of patients were 
affected [12].
The COVID-19 outbreak in Italy, and indeed through-
out the world, illustrates the need for a different type of 
care during pandemics. The reorganization of healthcare 
facilities to care for the overwhelming number of severe 
patients with easily transmittable disease resulted in re-
duced care and resources for patients with other urgent 
and emergent conditions. This is apparent in the ob-
served decrease in patients with urgent and emergent 
urological conditions reported here. The hospitalization 
rate for COVID-19 patients is approximately 50%, while 
16% of COVID-19 patients require ICU care [4]. This in-
creased need to care for COVID-19 patients means there 
are fewer resources and personnel to care for patients 
with other urgent and emergent conditions. Indeed, 
healthcare workers are also at risk of becoming patients 
themselves. It has been estimated that 85% of healthcare 
workers will be exposed to the virus [13], and the Inter-
national Council of Nurses estimated an infection rate of 
9% in Italy [14].
This study was, as the situation warranted, conduct-
ed with careful haste. It provides a snapshot of the effect 
that the COVID-19 pandemic has on access to urgent 
and emergent care. However, although urological cen-
tres from across Italy were included and thus are likely 
representative of urological practice throughout the 
country, there could, of course, be aberrations, with 
only 27 centres reporting here. Additionally, although 
it is likely that these same patterns would be observed 
in any other specialty, this work is limited to urological 
data. Finally, although Italy’s healthcare system is on 
par with those across Europe, some aspects of these 
findings may not be directly transferable to other Euro-
pean countries because of systematic and cultural dif-
ferences.
Acknowledging these limitations, the current paper 
represents the first series so far exploring the impact of 
COVID-19 on the access to care for patients with ur-
gent urological conditions. In particular, our findings 
strongly suggest that further protocols and facilities 
would be needed to provide care also for those patients 
who will inevitably develop other urgent conditions, ir-
respective of the COVID-19 pandemic. In this context, 
we identified future perspectives for the improvement 
of healthcare assistance: (1) create specific areas for 
the management and treatment of patients negative 
for COVID-19, either inside or outside of the exist- 
ing structures; (2) improve education regarding infec-
tious disease transmission for all healthcare providers; 
(3) meaningfully limit visitors’ access to reduce the risk 
of contagion and, at the same time, to enhance patients’ 
and employees’ safety; and (4) delaying urological sur-
gery should be considered whenever acceptable for the 
underlying disease, as reported by Stensland et al. [15], 
as a way of prioritizing the most urgent urological cas-
es.
Conclusions
This multicentre study of urological units in Italy 
found a significant decrease in the number of patients 
treated for urgent and emergent urological conditions 
across a 3-week period during the COVID-19 pandemic. 
It is reasonable to assume that these patterns are being 
observed in other specialties as well. Italy has been sub-
stantially affected by the COVID-19 outbreak, with the 
second highest number of diseased individuals and the 
highest death rate of COVID-19 patients as of the end of 
March 2020 [3]. This outbreak has affected not only indi-
viduals with COVID-19, but also patients seeking care for 
other urgent and emergent conditions. Continued re-
structuring of the healthcare system is necessary to be 
able to continue providing a high level of care to all pa-
tients, even during times of pandemics.
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